長川科技(300604.SZ):擬收購長奕投資97.6687%的股權 1月10日起停牌
格隆匯1月7日丨長川科技(300604.SZ)公佈,公司擬向天堂硅谷杭實、Lee Heng Lee 及井岡山樂橙發行股份購買其持有的長奕投資的97.6687%股權,並擬向不超過35名特定投資者發行股份募集配套資金。
標的公司持有的核心資產為EXIS TECH SDN. BHD.,主要業務係為半導體和自動化行業的測試部門設計和製造適配的測試設備及解決方案,核心產品為轉塔式分選機。
經公司申請,公司股票自2022年1月10日開市起開始停牌,預計停牌時間不超過10個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.